Literature DB >> 31848523

[Intraspinal metastasis of alveolar rhabdomyosarcoma: A case report].

G Z Lin1, Z Y Wang1, B Liu1, S M Yang2.   

Abstract

This paper reported a case of cervical intraspinal metastasis of alveolar rhabdomyosarcoma (ARMS). The clinicopathological features, surgical treatment, chemotherapy and prognosis were introduced and the current literature was reviewed. The diagnosis, differential diagnosis, treatment, molecular features and prognosis of the disease were comprehensively analyzed to improve clinicians' knowledge of this rare disease. The primary lesion appeared about 1 year ago which was painless mass of left hand whose size was about 2 cm×2 cm. After conservative treatment, the mass gradually enlarged and the mass was resected. Postoperative pathology revealed embryonic rhabdomyosarcoma. Postoperative chemotherapy with recombinant human endostatin, liposomal doxorubicin and ifosfamide was performed. The left neck mass was found about 3 months ago, and then the left neck mass was resected under general anesthesia. Postoperative pathological examination showed small round cell malignant tumors. Severe left upper extremity pain began about 2 weeks ago with nocturnal pain and supine pain. Non-steroidal anti-inflammatory drugs were needed to relieve pain which was accompanied by numbness and weakness of the left upper extremity. MRI showed a intraspinal tumor at C5. The left thumb and index finger were absent. Hypoesthesia, muscle atrophy and hypotonia of the left upper limb were confirmed. The muscle strength of biceps brachii and deltoid muscle of the left upper limb was grade 0, the muscle strength of extensor carpus and interphalangeal muscle was grade II, the muscle strength of intrinsic muscles of hands was grade I. The tendon reflex of the left upper limb disappeared. Intraspinal mass was removed and the pain was relieved. But there was no significant change in the muscle strength of the left upper limb. Pathological examination revealed small cell malignancies which were poorly differentiated with diffuse patchy distribution and disordered arrangement. The tumor cells had round, oval or irregular nuclei, and few cytoplasms were positive for Myogenin and MyoD1. FISH test of FOXO1 gene was positive. More than 50% of nuclei showed redgreen signal separation, and the distance between redgreen signals was larger than double diameter of the signal points, which supported ARMS. Total resection of intraspinal tumors was achieved and postoperative chemotherapy was admitted. But intraspinal disseminated metastasis occurred rapidly. ARMS was rare, aggressive tumor with poor prognosis. Subdural metastasis was rare. Correct diagnosis and classification can be made only with help of modern molecular diagnostic methods, which is effective to guide the treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31848523      PMCID: PMC7433573     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  6 in total

1.  Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features.

Authors:  Roberta La Starza; Valeria Nofrini; Tiziana Pierini; Valentina Pierini; Angelica Zin; Gianni Bisogno; Carla Cerri; Maurizio Caniglia; Angelo Sidoni; Kathrin Ludwig; Cristina Mecucci
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

Review 2.  Classification of rhabdomyosarcoma and its molecular basis.

Authors:  David M Parham; Frederic G Barr
Journal:  Adv Anat Pathol       Date:  2013-11       Impact factor: 3.875

Review 3.  Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances.

Authors:  Gabriela E Mercado; Frederic G Barr
Journal:  Curr Mol Med       Date:  2007-02       Impact factor: 2.222

4.  PAX immunoreactivity identifies alveolar rhabdomyosarcoma.

Authors:  Lisa M Sullivan; Kristen A Atkins; Robin D LeGallo
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

Review 5.  The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification.

Authors:  Christopher D M Fletcher
Journal:  Histopathology       Date:  2013-10-25       Impact factor: 5.087

Review 6.  Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.

Authors:  Daniela Egas-Bejar; Winston W Huh
Journal:  Adolesc Health Med Ther       Date:  2014-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.